1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > North America Haematology Market Outlook to 2021

North America Haematology Market Outlook to 2021

  • September 2015
  • -
  • Global Data
  • -
  • 254 pages

North America Haematology Market Outlook to 2021

Summary

GlobalData’s new report, "North America Haematology Market Outlook to 2021", provides key market data on the North America Haematology market. The report provides value, in millions of US dollars within market segments - Haematology Analyzers, Haemostasis, Haematology Reagents, Haematology Rapid Tests & POC, Haematology Cell Counters and Immunohaematology.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Haematology market includes Haematology Analyzers, Haemostasis, Haematology Reagents, Haematology Rapid Tests & POC, Haematology Cell Counters and Immunohaematology.
- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Haematology market.
- Global corporate-level profiles of key companies operating within the North America Haematology market.
- Key players covered include Danaher Corporation, Siemens Healthcare, Sysmex Corporation, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Immucor, Inc., Abbott Laboratories and bioMerieux S.A..

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table Of Contents

North America Haematology Market Outlook to 2021
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 7
2.1 What Is This Report About? 7
2.2 Haematology Market Segmentation 7
2.3 Definitions of Markets Covered in the Report 8
3 Haematology Market, North America 11
3.1 Haematology Market, North America, Revenue ($m), 2007-2021 11
3.2 Haematology Market, North America, Category Comparison by Revenue ($m), 2007-2021 13
3.3 Haematology Market, North America, Revenue ($m), 2007-2014 15
3.4 Haematology Market, North America, Revenue ($m), 2014-2021 17
3.5 Haematology Market, North America, Company Share by Revenue ($m), 2014 19
4 Haematology Market, Canada 21
4.1 Haematology Market, Canada, Revenue ($m), 2007-2014 21
4.2 Haematology Market, Canada, Revenue ($m), 2014-2021 23
4.3 Haematology Market, Canada, Distribution Share by Revenue ($m), 2013-2014 45
4.4 Haematology Market, Canada, Company Share by Revenue ($m), 2014 46
5 Haematology Market, Mexico 48
5.1 Haematology Market, Mexico, Revenue ($m), 2007-2014 48
5.2 Haematology Market, Mexico, Revenue ($m), 2014-2021 50
5.3 Haematology Market, Mexico, Distribution Share by Revenue ($m), 2013-2014 72
5.4 Haematology Market, Mexico, Company Share by Revenue ($m), 2014 73
6 Haematology Market, United States 75
6.1 Haematology Market, United States, Revenue ($m), 2007-2014 75
6.2 Haematology Market, United States, Revenue ($m), 2014-2021 77
6.3 Haematology Market, United States, Distribution Share by Revenue ($m), 2013-2014 99
6.4 Haematology Market, United States, Company Share by Revenue ($m), 2014 100
7 Overview of Key Companies in North America Haematology Market 102
7.1 Siemens Healthcare 102
7.2 Danaher Corporation 102
7.3 Bio-Rad Laboratories, Inc. 102
7.4 Sysmex Corporation 103
7.5 F. Hoffmann-La Roche Ltd. 103
7.6 Abbott Laboratories 103
7.7 Immucor, Inc. 103
7.8 bioMerieux S.A. 104
8 Haematology Market Pipeline Products 105
9 Financial Deals Landscape 107
9.1 Partnerships 107
10 Recent Developments 108
10.1 Corporate Communications 108
10.2 Financial Announcements 134
10.3 Legal And Regulatory 222
10.4 Other Significant Developments 224
10.5 Product News 236
10.6 Research And Development 239
10.7 Strategy And Business Planning 240
11 Appendix 246
11.1 Research Methodology 247
11.2 GlobalData Consulting 248
11.3 Contact Us 248
11.4 Disclaimer 249

1.1 List of Tables
Table 1: Haematology Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2007-2021 17
Table 2: Haematology Market, North America, Category Comparison by Revenue ($m), USD Constant, 2007-2021 19
Table 3: Haematology Market, North America, Revenue ($m), Historic, USD Constant, 2007-2014 21
Table 4: Haematology Market, North America, Revenue ($m), Forecast, USD Constant, 2014-2021 23
Table 5: Haematology Market, North America, Company Share by Revenue ($m), USD Constant, 2014 25
Table 6: Haematology Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 27
Table 7: Haematology Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 29
Table 8: Haematology Cell Counters Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 31
Table 9: Haematology Rapid Tests and POC Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 33
Table 10: Haematology Reagents Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 35
Table 11: Haemostasis Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 37
Table 12: Immunohaematology Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 39
Table 13: Haematology Cell Counters Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 41
Table 14: Haematology Rapid Tests and POC Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 43
Table 15: Haematology Reagents Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 45
Table 16: Haemostasis Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 47
Table 17: Immunohaematology Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 49
Table 18: Haematology Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2013-2014 50
Table 19: Haematology Market, Canada, Company Share by Revenue ($m), USD Constant, 2014 52
Table 20: Haematology Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014 54
Table 21: Haematology Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021 56
Table 22: Haematology Cell Counters Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014 58
Table 23: Haematology Rapid Tests and POC Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014 60
Table 24: Haematology Reagents Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014 62
Table 25: Haemostasis Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014 64
Table 26: Immunohaematology Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014 66
Table 27: Haematology Cell Counters Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021 68
Table 28: Haematology Rapid Tests and POC Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021 70
Table 29: Haematology Reagents Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021 72
Table 30: Haemostasis Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021 74
Table 31: Immunohaematology Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021 76
Table 32: Haematology Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2013-2014 77
Table 33: Haematology Market, Mexico, Company Share by Revenue ($m), USD Constant, 2014 79
Table 34: Haematology Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 81
Table 35: Haematology Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 83
Table 36: Haematology Cell Counters Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 85
Table 37: Haematology Rapid Tests and POC Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 87
Table 38: Haematology Reagents Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 89
Table 39: Haemostasis Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 91
Table 40: Immunohaematology Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 93
Table 41: Haematology Cell Counters Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 95
Table 42: Haematology Rapid Tests and POC Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 97
Table 43: Haematology Reagents Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 99
Table 44: Haemostasis Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 101
Table 45: Immunohaematology Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 103
Table 46: Haematology Market, United States, Distribution Share by Revenue ($m), USD Constant, 2013-2014 104
Table 47: Haematology Market, United States, Company Share by Revenue ($m), USD Constant, 2014 106
Table 48: Haematology Market Pipeline Products 110
Table 49: Vivione Biosciences Enters into Distribution Agreement with Trillium Diagnostics 112

1.2 List of Figures
Figure 1: Haematology Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2007-2021 16
Figure 2: Haematology Market, North America, Category Comparison by Revenue ($m), USD Constant, 2007-2021 18
Figure 3: Haematology Market, North America, Revenue ($m), Historic, USD Constant, 2007-2014 20
Figure 4: Haematology Market, North America, Revenue ($m), Forecast, USD Constant, 2014-2021 22
Figure 5: Haematology Market, North America, Company Share (%) 2014 24
Figure 6: Haematology Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 26
Figure 7: Haematology Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 28
Figure 8: Haematology Cell Counters Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 30
Figure 9: Haematology Rapid Tests and POC Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 32
Figure 10: Haematology Reagents Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 34
Figure 11: Haemostasis Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 36
Figure 12: Immunohaematology Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 38
Figure 13: Haematology Cell Counters Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 40
Figure 14: Haematology Rapid Tests and POC Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 42
Figure 15: Haematology Reagents Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 44
Figure 16: Haemostasis Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 46
Figure 17: Immunohaematology Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 48
Figure 18: Haematology Market, Canada, Company Share (%) 2014 51
Figure 19: Haematology Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014 53
Figure 20: Haematology Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021 55
Figure 21: Haematology Cell Counters Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014 57
Figure 22: Haematology Rapid Tests and POC Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014 59
Figure 23: Haematology Reagents Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014 61
Figure 24: Haemostasis Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014 63
Figure 25: Immunohaematology Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014 65
Figure 26: Haematology Cell Counters Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021 67
Figure 27: Haematology Rapid Tests and POC Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021 69
Figure 28: Haematology Reagents Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021 71
Figure 29: Haemostasis Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021 73
Figure 30: Immunohaematology Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021 75
Figure 31: Haematology Market, Mexico, Company Share (%) 2014 78
Figure 32: Haematology Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 80
Figure 33: Haematology Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 82
Figure 34: Haematology Cell Counters Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 84
Figure 35: Haematology Rapid Tests and POC Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 86
Figure 36: Haematology Reagents Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 88
Figure 37: Haemostasis Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 90
Figure 38: Immunohaematology Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 92
Figure 39: Haematology Cell Counters Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 94
Figure 40: Haematology Rapid Tests and POC Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 96
Figure 41: Haematology Reagents Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 98
Figure 42: Haemostasis Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 100
Figure 43: Immunohaematology Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 102
Figure 44: Haematology Market, United States, Company Share (%) 2014 105

Companies Mentioned
Siemens Healthcare
Danaher Corporation
Bio-Rad Laboratories, Inc.
Sysmex Corporation
F. Hoffmann-La Roche Ltd.
Abbott Laboratories
Immucor, Inc.
bioMerieux S.A.

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Competing in the Global Enteric Disease Testing Market

2016 Competing in the Global Enteric Disease Testing Market

  • $ 11500
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...

Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

  • $ 7500
  • Industry report
  • September 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...

World Enteric Diseases Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares by Test, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities

World Enteric Diseases Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares by Test, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities

  • $ 7500
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.